Pinokalant
Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region, and reduces the size of the lesion on magnetic resonance images in the acute phase after middle cerebral artery occlusion in rats.Pinokalant is a potential SARS-CoV-2 protease inhibitor for the study of stroke.
Product Specifications
CAS Number
149759-26-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
712.83
Molecular Formula
C41H48N2O9
Notes
Research use only, not for human use.
Receptor
TRP/TRPV Channel | SARS-CoV
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
